News

AVITA Medical to Release Q3 2025 Financial Results Soon

AVITA Medical to Release Q3 2025 Financial Results Soon

AVITA Medical Plans Third Quarter 2025 Financial Announcement

AVITA Medical, Inc. (NASDAQ: RCEL), a frontrunner in therapeutic acute wound care, is set to unveil its financial results for the third quarter of 2025. This significant event is scheduled to take place after the U.S. financial markets close on Thursday, November 6, 2025. As a leading player in the industry, AVITA Medical is dedicated to improving patient outcomes by delivering innovative solutions that foster rapid recovery from wounds.

Conference Call and Webcast Details

Following the financial announcement, the company will hold a conference call and webcast to discuss the results. The event will take place the same day at 1:30 PM Pacific Time. For international stakeholders, the broadcast is set for Friday, November 7, 2025, at 8:30 AM Australian Eastern Daylight Time. This session presents a prime opportunity for investors and analysts to gain insights directly from the company's management team.

How to Access the Webcast

Individuals interested in participating can access the live stream through the Events & Presentations section of the AVITA Medical website at ir.avitamedical.com. For those wishing to join via telephone, prior registration is necessary to obtain dial-in information and a unique PIN. This can be accomplished through a simple registration link provided by the company.

Insights into AVITA Medical's Comprehensive Product Offerings

AVITA Medical is at the forefront of advancing wound care technologies, and its flagship product, the RECELL System, is pivotal in its portfolio. This innovative system, recognized by the U.S. Food and Drug Administration, is designed to expedite healing for patients suffering from thermal burn and trauma wounds. By utilizing the patient’s own skin cells, RECELL creates a unique Spray-On Skin™ Cells solution that enhances clinical outcomes significantly.

Global Market Expansion

In addition to its U.S. offerings, the RECELL System has gained approval in international markets, allowing it to be used effectively for various skin healing applications. This includes regulatory clearances in European countries, along with Australia and Japan. This expansion showcases AVITA Medical’s commitment to making its leading-edge technologies available to a wider patient population across the globe.

Understanding the Company’s Mission and Vision

AVITA Medical's core mission focuses on delivering transformative healthcare solutions to patients. They aim to optimize patient recovery, ensuring that each individual receives the best possible care through state-of-the-art treatment options. With a team dedicated to excellence and innovation, the company continues to explore avenues for growth, all while maintaining its commitment to patient care.

Contact Information for Investors and Media

For those seeking additional insights about the company or its upcoming financial results, AVITA Medical has appointed Ben Atkins as the primary contact for media and investor inquiries. He can be reached by phone at +1-805 341 1571. For specific inquiries, parties can also reach out via email at investor@avitamedical.com or media@avitamedical.com.

Frequently Asked Questions

What is the purpose of AVITA Medical's upcoming financial results announcement?

The announcement will provide insights into the company’s financial performance for Q3 2025, highlighting revenue growth, expenses, and future outlook.

How can I access the conference call for the financial results?

You can access the conference call by visiting the AVITA Medical website under the Events & Presentations section. Participants can join via live webcast or telephone.

What are the main products offered by AVITA Medical?

AVITA Medical’s primary product is the RECELL System, which is used for creating Spray-On Skin™ Cells for treating burns and other trauma wounds.

Where is AVITA Medical expanding its market presence?

The company has expanded its market reach into international regions, including Europe, Australia, and Japan, where the RECELL System is now approved for various therapeutic applications.

How can I get in touch with AVITA Medical's investor relations?

You can contact Ben Atkins directly via phone or through the provided email addresses for investor inquiries or further information about the company.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Shareholder Votes Clear ODNB-NACB Merger's Final Hurdle

Updated Category News Views 24

A merger vote rarely makes anyone pound the table, but it does remove one very real way a bank deal can stumble. ODNB Financial Corporation and National Capital Bancorp, Inc. have announced that their shareholders approved the proposed merger. That is meaningful progress, plain and simple. It says the owners who get to live with the outcome have signed off on joining the...

Continue Reading
Siteimprove Turns Accessibility Checks Into Agent Spend

Updated Category News Views 37

Accessibility work has usually been the thing teams promise to fix after the launch party is over. Siteimprove is trying to shove that discipline directly into the AI-agent workflow, announcing on November 19, 2026 that its Siteimprove.ai Accessibility Agent is available through Agentic Commerce on AWS Marketplace. The practical hook is simple enough: an AI agent can...

Continue Reading
Würk's Bryte AI Targets Payroll's Costly Friction Points

Updated Category News Views 83

Payroll mistakes are the sort of paper cuts that suddenly turn into a hospital bill for an employer. Würk’s Nov. 19 launch of Bryte AI goes straight at that ugly reality in cannabis, beverage alcohol, and other heavily regulated workplaces, where a bad time entry, missed document, or misunderstood policy can create a far more expensive mess than ordinary office...

Continue Reading
LKQ’s Europe ERP Mess Turns Into a Credibility Test

Updated Category News Views 37

A software rollout should not be able to punch a company in the teeth twice, yet LKQ shareholders have watched precisely that ugly movie in 2026. The October 23 disclosure was a real gut-check: an immediate CEO departure, a $16 million net loss, and renewed acknowledgement that the German enterprise-resource-planning rollout was disrupting Europe. Shares fell $5.05, or...

Continue Reading
MedStar's Same-Day Test Puts Stroke Drugs on Notice

Updated Category News Views 25

A five-hour lab result can matter more than another glossy precision-medicine slogan. MedStar Health says it is using same-day genetic testing for patients with ischemic stroke, giving clinicians information before discharge that previously often arrived more than a week later. That is a practical change, not science-fiction wallpaper: a treatment decision gets made while...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 95

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
JLL’s Facility Management Push Gets a Useful Nod From Frost

Updated Category News Views 123

A Building Breaks Down Long Before the Earnings Call Notices Facility management is the sort of business that gets ignored until an airport system fails, a data-center cooling unit balks, or a workforce cannot use the building it was told to return to. That is why Frost & Sullivan’s 2026 recognition of JLL deserves more than the usual award-season shrug. It points to an...

Continue Reading
Action1's 3,688% Growth Puts Patching on Investor Maps

Updated Category News Views 52

Patch Management Finally Gets Some Respect Nothing makes a security buyer flinch faster than a machine carrying a known vulnerability for weeks, and Action1 has plainly found that nerve. The Houston-based autonomous endpoint management company says it was the fastest-growing endpoint management vendor on Deloitte's 2026 Technology Fast 500 for the second consecutive year,...

Continue Reading
Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 99

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
AIC Hotel Group's 11 Awards Test Resort Market Reach

Updated Category News Views 89

Eleven Trophies, Four Properties, One Useful Signal Hospitality awards can be a lot of polished brass and very little cash flow, but this batch is substantial enough to deserve a hard look. AIC Hotel Group collected 11 honors spanning Condé Nast Traveler's 2026 Readers' Choice Awards, Travel Weekly's 2026 Magellan Awards, and Good Housekeeping's 2027 Travel Awards. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Jyske Realkredit A/S Announces New Bond Listing Details

Updated Category News Views 192

Key Announcement about New Bond Listings On August 20, Jyske Realkredit A/S is set to introduce new bonds to the market. This announcement signals a pivotal moment for investors and the financial community alike. The company is preparing to list a novel type of Covered Bond (SDO) and a Mortgage Bond (RO), which could have significant implications for the current market...

Continue Reading
Maze Therapeutics Engages Investors at Major BioConnect Event

Updated Category News Views 168

Maze Therapeutics Engages Investors at a Major Event Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company, is making waves in the healthcare industry with its innovative approach to developing small molecule precision medicines. Their focus on addressing renal, metabolic, and cardiovascular diseases underscores the company's commitment to...

Continue Reading
Iterum Therapeutics Successfully Completes $5 Million Offering

Updated Category News Views 161

Iterum Therapeutics Completes Significant Offering Iterum Therapeutics plc (NASDAQ: ITRM), a biopharmaceutical company dedicated to creating innovative solutions against multi-drug resistant pathogens, has officially announced the successful closure of its recent direct offering. This strategic fundraising effort resulted in the sale of 5,555,556 ordinary shares, or the...

Continue Reading
Shopify Achieves Unprecedented Milestone with $14.6 Billion Sales

Updated Category News Views 210

Shopify's Impressive Holiday Sales Growth Shopify Inc. (NASDAQ: SHOP) has recently announced a phenomenal achievement, showcasing that merchants on its platform generated a staggering $14.6 billion in sales during the holiday shopping weekend. This impressive figure marks a magnificent 27% increase compared to the previous year, with approximately 81 million customers...

Continue Reading
Hotel Okura and AWC Set to Launch Unique Ryokan Hotels

Updated Category News Views 305

Hotel Okura and AWC Announce New Ryokan-Style Hotels In an exciting development for Thailand's hospitality sector, Hotel Okura Co., Ltd., a leading global player in the Japanese hotel industry, has partnered with Asset World Corporation (AWC). This collaboration will bring two new ryokan-style hotels to Chiang Mai and Bangkok, both slated to open by the year 2028. This...

Continue Reading